COH 0.21% $294.94 cochlear limited

the FY 14 results excluding the provision for patent dispute,...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,712 Posts.
    lightbulb Created with Sketch. 197
    the FY 14 results excluding the provision for patent dispute, are in line with the drop in revenue and somewhat the forex movement casper. Sure a profit fall is still a profit fall but it helps to understand the context than just what FY13 vs FY 14 was.

    That said, whether this is a buying opportunity rests on what you forsee happening now: will momentum as the chairman mentioned, pick up going forward as regulatory approvals and new sales come through? If so this will pick back up towards prior year profit levels (maybe not for the full year, given the dismal 1H14, but at least for 2H14).

    I see it going down abit more, and having gotten out post-fall in share price to $58 with the patent dispute, I'm happy to sit tight given the big fall.

    Unsure if $52 now will recover... with a dividend coming up. Might see some more major shareholders bail in next day or two so I might look to get back in on the short term on oversold share price.
 
watchlist Created with Sketch. Add COH (ASX) to my watchlist
(20min delay)
Last
$294.94
Change
-0.610(0.21%)
Mkt cap ! $19.30B
Open High Low Value Volume
$300.80 $300.80 $293.61 $35.77M 121.0K

Buyers (Bids)

No. Vol. Price($)
1 518 $294.90
 

Sellers (Offers)

Price($) Vol. No.
$295.33 361 1
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
COH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.